1843 Capital is an early-stage venture capital and private equity firm investing in technology and tech-enabled consumer packaged goods companies. It focuses on companies with women founders across sectors like biotech, FemTech, healthcare, and cybersecurity.
Key people at 1843 Capital.
Key people at 1843 Capital.
1843 Capital is an early-stage venture capital firm founded in 2016 by Tracy Chadwell, focused on investing in AgeTech (technology for older adults), Longevity, FinTech, and Cybersecurity sectors. The firm’s mission centers on supporting innovative startups, particularly those led by diverse founders, with capital, strategic guidance, and a unique sourcing strategy aimed at driving long-term value and growth. It primarily invests in Seed, Series A, and Series B rounds, emphasizing companies that address the needs of the aging population and other high-growth technology areas, thereby impacting the startup ecosystem by fostering innovation in underappreciated markets such as AgeTech and Longevity[1][3][6].
1843 Capital was named after the year Ada Byron Lovelace wrote the first computer program, symbolizing the firm’s commitment to pioneering innovation. Tracy Chadwell, the founding partner, brings over 19 years of venture capital and private equity experience, with a strong track record of supporting female founders and diverse teams. The firm has evolved to focus on sectors with significant growth potential and societal impact, such as AgeTech, which addresses the needs of the rapidly growing 65+ demographic controlling a substantial portion of disposable income in the U.S. The team includes experienced partners like Gwen Weiss, who brings financial and operational expertise to the firm[4][6][2].
1843 Capital rides the significant demographic and economic trend of an aging population, often called the "Silver Tsunami," with over 78 million Americans projected to be 65+ by 2030. This group controls 70% of disposable income, creating a $30 trillion market opportunity by 2050. The firm’s focus on AgeTech and Longevity aligns with growing societal needs for healthcare innovation, digital health, and supportive technologies for older adults. By investing early in these sectors, 1843 Capital influences the broader ecosystem by accelerating solutions that improve healthspan and quality of life, while also supporting diversity and inclusion in tech entrepreneurship[3][1].
Looking ahead, 1843 Capital is well-positioned to capitalize on the expanding AgeTech and Longevity markets, which will be shaped by advances in healthcare technology, digital diagnostics, and personalized care. The firm’s commitment to diverse founders and underappreciated sectors suggests it will continue to uncover high-potential startups that address critical societal challenges. As the aging population grows and technology adoption increases, 1843 Capital’s influence is likely to deepen, potentially expanding its fund size and portfolio impact while driving innovation that extends healthy lifespans and financial inclusion in tech[3][2][6].
